Suchergebnisse - "Arcaini, Luca"

PubPharm (373)

31

Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies : An Italian retrospective study

enthalten in: Hematological oncology | 2022

von Lanza, F. | Monaco, F. | Ciceri, F. | +19

CommentIn: Hematol Oncol. 2023 Feb;41(1):208-209. - PMID 36001740

32

Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies : A report from the ITA-HEMA-COV

enthalten in: Hematological oncology | 2022

von Zappasodi, P. | Cattaneo, C. | Valeria Ferretti, V. | +52

33

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients : A Real-Life Study from a COVID-19 Referral Centre in Northern Italy

enthalten in: Journal of clinical medicine | 2022

von Colaneri, M. | Pieri, T. | Roda, S. | +12

34

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas : The BArT Study of the Fondazione Italiana Linfomi

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Merli, M. | Rattotti, S. | Spina, M. | +23

35

Management of marginal zone lymphomas

enthalten in: Hematology. American Society of Hematology. Education Program | 2022

von Merli, M. | Arcaini, L.

36

Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment : A study of the International PCNSL Collaborative Group

enthalten in: British journal of haematology | 2022

von Steffanoni, S. | Calimeri, T. | Laurenge, A. | +25

37

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis : a study on 1258 patients

enthalten in: Leukemia | 2022

von Mora, B. | Guglielmelli, P. | Kuykendall, A. | +30

38

B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma

enthalten in: Hematological oncology | 2022

von Gragnani, L. | Lorini, S. | Marri, S. | +9

39

Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma : Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)

enthalten in: Hematological oncology | 2022

von Rigacci, L. | Battistini, R. | Kovalchuk, S. | +16

40

An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis

enthalten in: Leukemia | 2022

von Nevone, A. | Girelli, M. | Mangiacavalli, S. | +25